Larvol Delta - Abpro-Announces-Completion-of-Dosing-in-Phase-1-Study-of-its-Neutralizing-Antibody-Therapeutic-ABP-300-for-Treatment-of-COVID19

ABP-300 - Abpro Therap, BIO invest

http://www.globenewswire.com/news-release/2020/10/20/2111035/0/en/Abpro-Announces-Completion-of-Dosing-in-Phase-1-Study-of-its-Neutralizing-Antibody-Therapeutic-ABP-300-for-Treatment-of-COVID-19.html

Oct 20, 2020

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next